AMR Clinical

07/05/2025

We’re excited to announce our transition from The Alliance for Multispecialty Research to AMR Clinical. While our brand may be changing, our commitment to excellence remains the same. Backed by over 30 years of experience, more than 250,000 participants enrolled, and 8,000+ clinical trials completed, AMR Clinical continues to deliver on its promise:

Quality Without Compromise. Possibilities for Every Patient. Research Done Right.

Imagine a better clinical trial experience. One where expert sites are tailored to your indication and needs, strategically situated and ready when you need them. Where patients enroll effortlessly, opening doors to care options while accelerating your advancements. With AMR Clinical, this is more than a possibility; it’s how we do research.

Our refreshed brand reflects a legacy of excellence while looking forward to the future of our organization. It communicates our commitment to doing research the right way and delivering quality without compromise for everyone involved.

Participating in a trial with AMR Clinical gives you the opportunity to contribute to medical advancements and gain early access to innovative care. If you have any questions about our new branding, our mission to you, or clinical trials that are currently enrolling, please contact us at 757-614-1001 or NVArecruitment@amrllc.com.

15/01/2024

"Life's most persistent and urgent question is, 'What are you doing for others?'" - Martin Luther King, Jr.

Honoring Martin Luther King, Jr. Day.

01/01/2024

Happy New Year! We appreciate you and hope to continue our collaboration and our shared goals in the new year!

31/12/2023

Have a happy and safe New Year's Eve!

13/12/2023

AMR Continues Expansion with Acquisition of Affinity Health
Chicago, IL - Alliance for Multispecialty Research (AMR), a leading integrated research site organization, has acquired Affinity Health. Affinity Health, founded in 2015, provides clinical research delivery with exceptional patient care and safety. AMR’s acquisition of Affinity Health will continue to strengthen our position as an industry leader with 32 clinical research sites. According to CEO Bill Smith, MD, “This acquisition increases the AMR regional footprint and is another milestone in our goals around scalability and growth while maintaining our focus on patient centricity and patient diversity.”

Over the last 8 years, Affinity Health has focused on advancing the reaches of medicine for the overall betterment of healthcare everywhere. “I am extremely excited to become part of AMR. This step allows our Affinity Health sites to enter the next phase of growth with stronger support in infrastructure and standardization as we support continued advancements in clinical development,” says Ali Ahmed, President, Affinity Health.

Affinity’s clinical research centers offer specialized therapeutic focus as well as access to diverse patient populations. The addition of Affinity Health to AMR adds 8 new Principal Investigators to AMR with specialization across several key therapeutic areas. Together with their teams, they have experience in conducting research in Cardiology, Dermatology, Endocrinology, Internal Medicine, Orthopedics, Pulmonology, and Women's Health.

AMR’s strategic acquisition of Affinity Health provides access to several key markets in Chicago, IL and Nashville, TN. “Identifying diverse clinical trial subjects continues to be a priority for AMR as we expand our capabilities geographically and therapeutically. The Affinity sites add additional depth in several key therapeutic areas such as Cardiology, Dermatology, and Endocrinology,” explained AMR Chief Operating Officer Kari Delahunty, MBA.
For more information, visit www.amrllc.com or contact AMR directly at 615-591-0211.

About AMR
AMR is the leading independent site management company with a 30-year history of successfully executing clinical trials across a network of 32 clinical sites. The Company has over 130 dedicated principal investigators with more than 400 years of combined experience across 20+ therapeutic areas, providing its pharmaceutical sponsor and CRO clients unparalleled access to patients. AMR’s experience and scale allow it to deliver improved efficiencies and exceptional clinical quality. AMR is headquartered in Knoxville, Tennessee.

21/11/2023

We are thankful.

"Professionally, I am truly grateful for the opportunity to be on the cutting edge of medicine in clinical research. The ability to contribute to advancements in healthcare and potentially make a positive impact on the lives of individuals is a privilege. And to do so alongside a team of amazing folks at AMR is an incredible honor...... Personally, I am profoundly thankful for the abundance of blessings in my life. For the experiences that have shaped my journey and provided me with opportunities for growth and learning and enriched my existence. For the love and support of family. For the tapestry of friendships. For the beauty and diversity of this world."
Nancy Cleverly, Regional Vice President of Operations

We are AMR.

11/11/2023

Honoring all who served on Veterans Day. Thank you for your service.

05/11/2023

It's Daylight Savings time! Fall back one hour - and use that extra time to learn more about clinical research! Visit www.amrllc.com today!

31/10/2023

Have a safe and happy Halloween!

19/10/2023

AMR Principal Investigator Dr. Jeffrey Rosen, nominee for the Christine Pierre Clinical Trials Lifetime Achievement Award, discusses changes in the landscape of clinical research during his 40 plus years in The Industry.

To vote for Dr. Jeffrey Rosen, long-time AMR Principal Investigator, please visit https://bit.ly/45euAdVVoting will be available now until October 24, 2023. ...

17/10/2023

THE NOMINATION: As we have already expressed, AMR's very own Dr. Jeffrey Rosen has been nominated for the Christine Pierre Clinical Trials Lifetime Achievement Award.

This award celebrates the ground-breaking work and contributions of individuals across the field of clinical trials who are making a positive difference. According to Clinical Trials Europe, this award showcases and rewards that hard work with a trophy and exposure to their global audience. There are five individuals on the shortlist of nominees. Voting for the final recipient is currently underway and will last until October 24, 2023. The winner will be announced during the Clinical Trials Europe conference in Barcelona this November.

To vote for Dr. Rosen, please visit https://bit.ly/45euAdV

To learn more about Dr. Rosen and how he learned of his nomination, please view the included video.

Voting will be available now until October 24, 2023. During this time, we will keep you updated with voting reminders, information you can share with others within our industry, press releases, social media posts and more. Thank you for your consideration!
https://youtu.be/8pdx9do6rkA?si=LW64gvtIixGI9EUS

MIAMI, Florida – Dr. Jeffrey Rosen, Chief Medical Officer for Alliance for Multispecialty Research (AMR), has been nominated for the Christine Pierre Lifetim...

13/10/2023

Fun Fact Friday is back! And better than ever with this unbelievable photo that really brings the HEAT! Over ten years ago, Dr. Jeffrey Rosen, AMR Principal Investigator and long-time Miami Heat season ticket owner, was at a Heat event. There, he had the opportunity to meet a few of the Heat’s best players better known as “The Big Three.” That includes Chris Bosh, Dwyane Wade and THE LeBron James. Dr. Rosen poses with “The Big Three” in this photo, but many people have always believed this picture was photoshopped. It wasn’t.

Dr. Rosen was recently nominated for the Christine Pierre Clinical Trials Lifetime Achievement Award. LeBron James once said “basketball is my passion, I love it” Dr. Rosen feels the same about clinical research. With over 40 years within the industry, Dr. Rosen is humbled by this Lifetime Achievement Award nomination.

“I have had the privilege to participate in over 800 clinical trials, serving as a dedicated advocate for advancing healthcare. I’m proud to have worked on many of the trials that have resulted in so many of the medications and vaccines we use every day,” expressed Dr. Rosen.

To cast your vote for Dr. Rosen, please visit: https://get.informaconnect.com/clinical-trials-europe/lifetime-achievement-award/vote-2023/?_gl=1*qo60e*_gcl_au*MzYwMzg1NTgwLjE2OTY0MjY2MDg.&_ga=2.226986910.2048443705.1696623797-46309554.1696426608&fbclid=IwAR3ZL5s0jGw4PuxPtfIjod6qdfHFZRzzqCd6uyJADDuf5PIeOsp4vTGiIXc